Skip to main content

Articles

Ninety Years of Insulin: What’s Needed? What’s New?
Read More
FDA Approvals
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Read More
Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes
Read More
The Diabetes Epidemic Is Like a Tsunami Hitting in Waves
Read More
FDA Approvals
Lixisenatide Continues to Show Good Results in GetGoal Program Studies
Read More
FDA Approvals
Novel Basal Insulin LY2605541 Lowers Blood Glucose, Enhances Weight Loss
Read More
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Read More
Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management
Read More
Medical Costs Increase as Chronic Kidney Disease Worsens
Read More
Value-Based Benefit Design: Reducing Copayment for High-Value Services Maximizes Return on Investment
Read More
Page 195 of 244
Results 1941 - 1950 of 2434